Sage Therapeutics (SAGE) Earnings Date, Estimates & Call Transcripts $8.60 +0.07 (+0.82%) Closing price 04:00 PM EasternExtended Trading$8.54 -0.06 (-0.76%) As of 06:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Sage Therapeutics Latest Earnings SummaryUpcoming Q1 Earnings DateApr. 24After Market ClosesEstimatedActual EPS (Feb. 11) -$1.56 Missed By -$0.02 Consensus EPS (Feb. 11) -$1.54 Sage Therapeutics released Q4 2024 earnings on February 11, 2025, reporting an EPS of -$1.56, which missed the consensus estimate of -$1.54 by $0.02. With a trailing EPS of -$6.59, Sage Therapeutics' earnings are expected to grow next year, from ($3.52) to ($2.52) per share. Conference CallConference Call TranscriptSAGE Upcoming EarningsSage Therapeutics' next earnings date is estimated for Thursday, April 24, 2025, based off prior year's reporting schedules. Get Sage Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sage Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataSAGE Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SAGE Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Sage Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20254-$1.64-$1.03-$1.26Q2 20254-$1.56-$0.99-$1.15Q3 20254-$1.55-$0.15-$0.91Q4 20254-$1.54-$0.93-$1.11FY 202516($6.29)($3.10)($4.43) Remove Ads Sage Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 4/24/2025(Estimated)-------2/11/2025Q4 2024-$1.54-$1.56 -$0.02-$1.56$14.37M-10/29/2024Q3 2024-$1.52-$1.53 -$0.01-$1.53$10.80M$11.87M7/31/2024Q2 2024-$1.68-$1.70 -$0.02-$1.70$8.85M$8.65M4/25/2024Q1 2024-$1.63-$1.80 -$0.17-$1.80$5.26M$7.90M2/14/2024Q4 2023-$1.28-$0.55+$0.73-$0.55$60.15M$77.97M11/7/2023Q3 2023-$2.64-$2.81 -$0.17-$2.25$9.02M$2.72M8/7/2023Q2 2023-$2.55-$2.68 -$0.13-$2.68$2.94M$2.47M5/2/2023Q1 2023-$2.50-$2.46+$0.04-$2.46$2.28M$3.30M Sage Therapeutics Earnings - Frequently Asked Questions When is Sage Therapeutics's earnings date? Sage Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 24th, 2025 based off last year's report dates. Learn more on SAGE's earnings history. Did Sage Therapeutics beat their earnings estimates last quarter? In the previous quarter, Sage Therapeutics (NASDAQ:SAGE) missed the analysts' consensus estimate of ($1.54) by $0.02 with a reported earnings per share (EPS) of ($1.56). Learn more on analysts' earnings estimate vs. SAGE's actual earnings. How can I listen to Sage Therapeutics's earnings conference call? The conference call for Sage Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Sage Therapeutics's conference call transcript? The conference call transcript for Sage Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does Sage Therapeutics generate each year? Sage Therapeutics (NASDAQ:SAGE) has a recorded annual revenue of $41.24 million. How much profit does Sage Therapeutics generate each year? Sage Therapeutics (NASDAQ:SAGE) has a recorded net income of -$400.67 million. SAGE has generated -$6.59 earnings per share over the last four quarters. What is Sage Therapeutics's EPS forecast for next year? Sage Therapeutics's earnings are expected to grow from ($3.52) per share to ($2.52) per share in the next year. More Earnings Resources from MarketBeat Related Companies Tarsus Pharmaceuticals Earnings Harmony Biosciences Earnings Travere Therapeutics Earnings Janux Therapeutics Earnings Disc Medicine Earnings Agios Pharmaceuticals Earnings Apogee Therapeutics Earnings Vera Therapeutics Earnings Galapagos Earnings Kiniksa Pharmaceuticals Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles After Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside?These 3 Q1 Earnings Winners Will Go HigherWhat Is the Price-to-Earnings (P/E) Ratio?Analysts Lift Archer Aviation Stock Despite Earnings Miss DigitalOcean Rides Cloud Wave and AI Hype to Strong EarningsPrice Targets on NVIDIA Rise in Front of Earnings Remove Ads This page (NASDAQ:SAGE) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sage Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sage Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SAGE Stock Free SAGE Stock Alerts